(Q41348602)

29 September 2017

0 references

Optimal use of methotrexate: the advantages of tight control (English)

1 reference

29 September 2017

1 reference

J W J Bijlsma

1

1 reference

29 September 2017

M E Weinblatt

series ordinal

2

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

Annals of the Rheumatic Diseases

29 September 2017

1 reference

29 September 2017

66

1 reference

29 September 2017

11

1 reference

29 September 2017

1409-1410

1 reference

Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2111621

New therapies for treatment of rheumatoid arthritis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2111621

Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2111621

Remission of rheumatoid arthritis: should we care about definitions?

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2111621

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2111621

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2111621

Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial

11 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2111621

The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2111621

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

19 August 2018

1 reference

12 December 2020

Treating rheumatoid arthritis early: a window of opportunity?

1 reference

12 December 2020

The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had

1 reference

12 December 2020

The BeSt way to treat early rheumatoid arthritis?

1 reference

12 December 2020

Rationale and strategies for reevaluating the ACR20

1 reference

12 December 2020

Regression to the mean using the disease activity score in eligibility and response criteria for prescribing TNF-alpha inhibitors in adults with rheumatoid arthritis

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.2007.076463

1 reference

release_giiqqlkyeve7blxubifqe3hkty

29 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/giiqqlkyeve7blxubifqe3hkty

24 November 2022

mapped directly with Wikidata item

1 reference

29 September 2017

PubMed publication ID

17934080

1 reference